Literature DB >> 31346658

New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism.

Stephanie Eid1, Kelli M Sas2, Steven F Abcouwer3, Eva L Feldman1, Thomas W Gardner3,4, Subramaniam Pennathur2,4, Patrice E Fort5,6.   

Abstract

Diabetes adversely affects multiple organs, including the kidney, eye and nerve, leading to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy, respectively. In both type 1 and type 2 diabetes, tissue damage is organ specific and is secondary to a combination of multiple metabolic insults. Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. Only recently have the commonalities and differences in the metabolic basis of these tissue-specific complications, particularly those involving local and systemic lipids, been systematically examined. This review focuses on recent progress made using preclinical models and human-based approaches towards understanding how bioenergetics and metabolomic profiles contribute to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. This new understanding of the biology of complication-prone tissues highlights the need for organ-specific interventions in the treatment of diabetic complications.

Entities:  

Keywords:  Diabetes; Diabetic complications; Lipid metabolism; Omics; Review; Specific mechanisms

Mesh:

Year:  2019        PMID: 31346658      PMCID: PMC6679814          DOI: 10.1007/s00125-019-4959-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  113 in total

Review 1.  Clinical review 124: Diabetic dyslipidemia: causes and consequences.

Authors:  I J Goldberg
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

2.  Complete metabolome and lipidome analysis reveals novel biomarkers in the human diabetic corneal stroma.

Authors:  Shrestha Priyadarsini; Tina B McKay; Akhee Sarker-Nag; Jeremy Allegood; Charles Chalfant; Jian-Xing Ma; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2016-10-11       Impact factor: 3.467

Review 3.  Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.

Authors:  Szu-chi Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

4.  Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

Authors:  Qiuping Liu; Fengjun Zhang; Xian Zhang; Rui Cheng; Jian-Xing Ma; Jinglin Yi; Jingming Li
Journal:  Mol Cell Biochem       Date:  2017-12-21       Impact factor: 3.396

5.  Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Authors:  Pedro Romero; Mercè Salvat; Juan Fernández; Marc Baget; Inmaculada Martinez
Journal:  J Diabetes Complications       Date:  2007 Mar-Apr       Impact factor: 2.852

6.  Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  Barbara E K Klein; Chelsea E Myers; Kerri P Howard; Ronald Klein
Journal:  JAMA Ophthalmol       Date:  2015-05       Impact factor: 7.389

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications.

Authors:  D Willems; H Dorchy; D Dufrasne
Journal:  Atherosclerosis       Date:  1998-04       Impact factor: 5.162

9.  Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.

Authors:  Lexi Ding; Rui Cheng; Yang Hu; Yusuke Takahashi; Alicia J Jenkins; Anthony C Keech; Kenneth M Humphries; Xiaowu Gu; Michael H Elliott; Xiaobo Xia; Jian-Xing Ma
Journal:  Am J Pathol       Date:  2014-08-07       Impact factor: 4.307

10.  Diabetes and obesity are the main metabolic drivers of peripheral neuropathy.

Authors:  Brian C Callaghan; LeiLi Gao; Yufeng Li; Xianghai Zhou; Evan Reynolds; Mousumi Banerjee; Rodica Pop-Busui; Eva L Feldman; Linong Ji
Journal:  Ann Clin Transl Neurol       Date:  2018-02-14       Impact factor: 4.511

View more
  73 in total

1.  High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo.

Authors:  Marija Sajic; Amy E Rumora; Anish A Kanhai; Giacomo Dentoni; Sharlini Varatharajah; Caroline Casey; Ryan D R Brown; Fabian Peters; Lucy M Hinder; Masha G Savelieff; Eva L Feldman; Kenneth J Smith
Journal:  J Neurosci       Date:  2021-03-30       Impact factor: 6.167

Review 2.  Basic Mechanisms of Diabetic Heart Disease.

Authors:  Rebecca H Ritchie; E Dale Abel
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

Review 3.  Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies.

Authors:  Kelley Newlin Lew; Tracey Arnold; Catherine Cantelmo; Francky Jacque; Hugo Posada-Quintero; Pooja Luthra; Ki H Chon
Journal:  J Diabetes Sci Technol       Date:  2022-01-07

Review 4.  Regulation of endothelial progenitor cell functions during hyperglycemia: new therapeutic targets in diabetic wound healing.

Authors:  Gui Wan; Yangyang Chen; Jing Chen; Chengqi Yan; Cheng Wang; Wenqing Li; Renqun Mao; Hans-Günther Machens; Xiaofan Yang; Zhenbing Chen
Journal:  J Mol Med (Berl)       Date:  2022-01-08       Impact factor: 4.599

5.  A nomogram for predicting 5-year incidence of type 2 diabetes in a Chinese population.

Authors:  Zeyin Lin; Dongming Guo; Juntian Chen; Baoqun Zheng
Journal:  Endocrine       Date:  2019-12-09       Impact factor: 3.633

6.  Retinopathy in a Diet-Induced Type 2 Diabetic Rat Model and Role of Epigenetic Modifications.

Authors:  Renu A Kowluru
Journal:  Diabetes       Date:  2020-01-16       Impact factor: 9.461

Review 7.  Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy.

Authors:  Amro M Stino; Amy E Rumora; Bhumsoo Kim; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2020-06       Impact factor: 3.494

Review 8.  Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms.

Authors:  Daniel Gonzalez Izundegui; Matthew Nayor
Journal:  Curr Diab Rep       Date:  2022-02-03       Impact factor: 4.810

Review 9.  Diabetic neuropathy: what does the future hold?

Authors:  Brian C Callaghan; Gary Gallagher; Vera Fridman; Eva L Feldman
Journal:  Diabetologia       Date:  2020-01-23       Impact factor: 10.122

10.  Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial.

Authors:  Benedetta Maria Bonora; Mattia Albiero; Mario Luca Morieri; Roberta Cappellari; Francesco Ivan Amendolagine; Marta Mazzucato; Alberto Zambon; Elisabetta Iori; Angelo Avogaro; Gian Paolo Fadini
Journal:  Diabetologia       Date:  2021-08-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.